Oral Fluid and Saliva Drug Testing Market Report – Research, Industry Analysis Reports and Market Demands

Global Oral Fluid and Saliva Drug Testing Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oral Fluid and Saliva Drug Testing Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Consumables
- 1.3.3 Equipment
1.4 Market Analysis by Sales Channels
- 1.4.1 Overview: Global Oral Fluid and Saliva Drug Testing Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.4.2 Online Sales
- 1.4.3 Offline Sales
1.5 Market Analysis by Testing Items
- 1.5.1 Overview: Global Oral Fluid and Saliva Drug Testing Consumption Value by Testing Items: 2021 Versus 2025 Versus 2032
- 1.5.2 Single-Panel
- 1.5.3 Multi-Panel
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Oral Fluid and Saliva Drug Testing Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Traffic Safety & Roadside Testing
- 1.6.3 Workplace Testing
- 1.6.4 Healthcare & Rehabilitation
- 1.6.5 Others
1.7 Global Oral Fluid and Saliva Drug Testing Market Size & Forecast
- 1.7.1 Global Oral Fluid and Saliva Drug Testing Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Oral Fluid and Saliva Drug Testing Sales Quantity (2021-2032)
- 1.7.3 Global Oral Fluid and Saliva Drug Testing Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Oral Fluid and Saliva Drug Testing by Manufacturer

3.1 Global Oral Fluid and Saliva Drug Testing Sales Quantity by Manufacturer (2021-2026)
3.2 Global Oral Fluid and Saliva Drug Testing Revenue by Manufacturer (2021-2026)
3.3 Global Oral Fluid and Saliva Drug Testing Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Oral Fluid and Saliva Drug Testing by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Oral Fluid and Saliva Drug Testing Manufacturer Market Share in 2025
- 3.4.3 Top 6 Oral Fluid and Saliva Drug Testing Manufacturer Market Share in 2025
3.5 Oral Fluid and Saliva Drug Testing Market: Overall Company Footprint Analysis
- 3.5.1 Oral Fluid and Saliva Drug Testing Market: Region Footprint
- 3.5.2 Oral Fluid and Saliva Drug Testing Market: Company Product Type Footprint
- 3.5.3 Oral Fluid and Saliva Drug Testing Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Oral Fluid and Saliva Drug Testing Market Size by Region
- 4.1.1 Global Oral Fluid and Saliva Drug Testing Sales Quantity by Region (2021-2032)
- 4.1.2 Global Oral Fluid and Saliva Drug Testing Consumption Value by Region (2021-2032)
- 4.1.3 Global Oral Fluid and Saliva Drug Testing Average Price by Region (2021-2032)
4.2 North America Oral Fluid and Saliva Drug Testing Consumption Value (2021-2032)
4.3 Europe Oral Fluid and Saliva Drug Testing Consumption Value (2021-2032)
4.4 Asia-Pacific Oral Fluid and Saliva Drug Testing Consumption Value (2021-2032)
4.5 South America Oral Fluid and Saliva Drug Testing Consumption Value (2021-2032)
4.6 Middle East & Africa Oral Fluid and Saliva Drug Testing Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Oral Fluid and Saliva Drug Testing Sales Quantity by Type (2021-2032)
5.2 Global Oral Fluid and Saliva Drug Testing Consumption Value by Type (2021-2032)
5.3 Global Oral Fluid and Saliva Drug Testing Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Oral Fluid and Saliva Drug Testing Sales Quantity by Application (2021-2032)
6.2 Global Oral Fluid and Saliva Drug Testing Consumption Value by Application (2021-2032)
6.3 Global Oral Fluid and Saliva Drug Testing Average Price by Application (2021-2032)

7 North America

7.1 North America Oral Fluid and Saliva Drug Testing Sales Quantity by Type (2021-2032)
7.2 North America Oral Fluid and Saliva Drug Testing Sales Quantity by Application (2021-2032)
7.3 North America Oral Fluid and Saliva Drug Testing Market Size by Country
- 7.3.1 North America Oral Fluid and Saliva Drug Testing Sales Quantity by Country (2021-2032)
- 7.3.2 North America Oral Fluid and Saliva Drug Testing Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Oral Fluid and Saliva Drug Testing Sales Quantity by Type (2021-2032)
8.2 Europe Oral Fluid and Saliva Drug Testing Sales Quantity by Application (2021-2032)
8.3 Europe Oral Fluid and Saliva Drug Testing Market Size by Country
- 8.3.1 Europe Oral Fluid and Saliva Drug Testing Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Oral Fluid and Saliva Drug Testing Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Oral Fluid and Saliva Drug Testing Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Oral Fluid and Saliva Drug Testing Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Oral Fluid and Saliva Drug Testing Market Size by Region
- 9.3.1 Asia-Pacific Oral Fluid and Saliva Drug Testing Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Oral Fluid and Saliva Drug Testing Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Oral Fluid and Saliva Drug Testing Sales Quantity by Type (2021-2032)
10.2 South America Oral Fluid and Saliva Drug Testing Sales Quantity by Application (2021-2032)
10.3 South America Oral Fluid and Saliva Drug Testing Market Size by Country
- 10.3.1 South America Oral Fluid and Saliva Drug Testing Sales Quantity by Country (2021-2032)
- 10.3.2 South America Oral Fluid and Saliva Drug Testing Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Oral Fluid and Saliva Drug Testing Market Size by Country
- 11.3.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Oral Fluid and Saliva Drug Testing Market Drivers
12.2 Oral Fluid and Saliva Drug Testing Market Restraints
12.3 Oral Fluid and Saliva Drug Testing Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Oral Fluid and Saliva Drug Testing and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Fluid and Saliva Drug Testing
13.3 Oral Fluid and Saliva Drug Testing Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Oral Fluid and Saliva Drug Testing Typical Distributors
14.3 Oral Fluid and Saliva Drug Testing Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Oral Fluid and Saliva Drug Testing market size was valued at US$ 185 million in 2025 and is forecast to a readjusted size of US$ 238 million by 2032 with a CAGR of 3.9% during review period.
Oral Fluid and Saliva Drug Testing refers to a category of products and systems that use oral fluid or saliva specimens to rapidly screen or confirm drugs of abuse and related substances such as cannabinoids, amphetamines, opiates, cocaine and its metabolites, benzodiazepines, and methadone. In commercial practice, "Oral Fluid" and "Saliva" are commonly used in parallel. The main product forms include collection swabs, integrated test devices, buffer solutions, and reader instruments. This testing approach offers advantages such as non-invasive collection, observable sampling, convenient operation, and suitability for on-site testing, which has supported its expanding use in roadside enforcement, workplace screening, judicial and forensic applications, rehabilitation programs, and selected medical testing scenarios. Upstream raw materials mainly include antibodies, antigens and other bioactive materials, nitrocellulose membranes, colloidal gold or latex particles, plastic injection-molded components, collection swabs, buffer reagents, electronic components, and packaging materials. Downstream customers mainly include police and traffic enforcement agencies, third-party drug testing service providers, corporate pre-employment and workplace screening departments, judicial institutions, rehabilitation centers, and professional distributors. On an ex-factory basis, global nominal capacity for Oral Fluid and Saliva Drug Testing is estimated at about 38.00 million units in 2025, with sales volume of about 28.60 million units, an average ex-factory price of about US$6.30 per unit, and an overall industry gross margin of around 45%-55%.
The market is gradually moving toward a structure in which urine testing remains the installed base, while oral fluid testing continues to gain share. Compared with urine-based methods, oral fluid testing offers clearer advantages in observed collection, shorter collection procedures, and lower risks of sample substitution or adulteration. As regulatory frameworks become more established, oral fluid testing is moving from a supplementary option toward a more formal and standardized role. End users are also paying increasing attention to collection visibility, specimen integrity, confirmation linkage, and overall compliance delivery.
From an application perspective, oral fluid testing is not simply replacing urine testing. Instead, the two methods are becoming more complementary across different scenarios. Oral fluid testing is gaining relevance in roadside enforcement, safety-sensitive jobs, judicial support screening, and selected high-mobility workforce settings, while urine testing still holds a stable position in programs that prioritize lower cost, large-scale volume, and mature workflows. As a result, competition is expanding from individual products toward broader solution capabilities covering collection devices, assay performance, confirmation support, staff training, quality systems, and service coordination.
Looking ahead, oral fluid testing is likely to continue developing through broader application, more standardized workflows, and more integrated service models. As users gain more operational experience, acceptance in on-site screening, observed collection, and rapid turnaround settings is expected to improve further. At the same time, customer requirements will increasingly focus on result consistency, specimen stability, interference resistance, data continuity, and auditability. For suppliers, future differentiation will depend more on total solution capability than on the test device alone.
The main growth drivers include stronger compliance requirements, rigid risk-control needs in safety-sensitive sectors, rising employer attention to testing efficiency and specimen authenticity, and the need to upgrade screening approaches as drug-use patterns become more complex. At the same time, the market still faces clear constraints, including regulatory differences across regions, higher training demands for collection and confirmation workflows, long validation cycles, meaningful switching costs, and stricter expectations for result acceptance and confirmation linkage. Overall, the industry shows clear demand potential, but the barriers for product execution, service delivery, and compliance capability are also rising.
This report is a detailed and comprehensive analysis for global Oral Fluid and Saliva Drug Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Fluid and Saliva Drug Testing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Fluid and Saliva Drug Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Fluid and Saliva Drug Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Fluid and Saliva Drug Testing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Fluid and Saliva Drug Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Fluid and Saliva Drug Testing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Draeger, Abbott Laboratories, Securetec Detektions-Systeme, Thermo Fisher Scientific, Oranoxis, Premier Biotech, Healgen Scientific, Lin-Zhi International, Neogen Corporation, UCP Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Fluid and Saliva Drug Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Consumables
Equipment
Market segment by Sales Channels
Online Sales
Offline Sales
Market segment by Testing Items
Single-Panel
Multi-Panel
Market segment by Application
Traffic Safety & Roadside Testing
Workplace Testing
Healthcare & Rehabilitation
Others
Major players covered
Draeger
Abbott Laboratories
Securetec Detektions-Systeme
Thermo Fisher Scientific
Oranoxis
Premier Biotech
Healgen Scientific
Lin-Zhi International
Neogen Corporation
UCP Biosciences
American Screening Corp
Randox Laboratories
AccuBioTech
Assure Tech (Hangzhou)
Wondfo Biotech
Hangzhou Biotest Biotech
Dochekbio
Venture Biotechnology
Prometheus
Core Technology
Jiangsu Well Biotech Co., Ltd.
Shanghai Chemtron Biotech
Hangzhou Laihe Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Fluid and Saliva Drug Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Fluid and Saliva Drug Testing, with price, sales quantity, revenue, and global market share of Oral Fluid and Saliva Drug Testing from 2021 to 2026.
Chapter 3, the Oral Fluid and Saliva Drug Testing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Fluid and Saliva Drug Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Fluid and Saliva Drug Testing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Fluid and Saliva Drug Testing.
Chapter 14 and 15, to describe Oral Fluid and Saliva Drug Testing sales channel, distributors, customers, research findings and conclusion.

Buy now